The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland

Ir Med J. Jan-Feb 2000;93(1):17-8.

Abstract

It has been suggested that routine antenatal prophylactic anti-D should be introduced for prevention of Rhesus D (RhD) haemolytic disease. Before making changes to the current prevention program it is important, therefore, to have up-to-date data on affected infants. Pregnant women with anti-D antibodies between September 1994 and February 1997 were identified by the Northern Ireland Blood Transfusion Service. The records of 124 women and 130 babies were examined. 26% of planned deliveries occurred in hospitals without paediatric cover. Rhesus isoimmunisation affected 78 babies. Fifty-nine infants were admitted to one of seven neonatal units. There were 2 stillbirths and 1 neonatal death. Two infants have severe neurodevelopmental delay. There is still significant morbidity associated with RhD haemolytic disease. Care for RhD affected pregnancies should be centralised to guarantee training opportunities and maintenance of expertise. The current management of these pregnancies should be re-examined before changing the Rhesus prevention program.

MeSH terms

  • Erythroblastosis, Fetal / epidemiology
  • Erythroblastosis, Fetal / prevention & control*
  • Female
  • Humans
  • Infant, Newborn
  • Northern Ireland / epidemiology
  • Pregnancy
  • Pregnancy Outcome
  • Registries
  • Rh Isoimmunization / epidemiology*
  • Rho(D) Immune Globulin / administration & dosage*

Substances

  • Rho(D) Immune Globulin